Menu
Back to User profile » Dr Claudio Marcassa
Papers published by Dr Claudio Marcassa:
Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability
Bandinelli F, Scazzariello F, Pimenta da Fonseca E, Barreto Santiago M, Marcassa C, Nacci F, Matucci Cerinic M
Drug Design, Development and Therapy 2016, 10:3717-3724
Published Date: 14 November 2016
Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain: an observational analysis
De Santis S, Borghesi C, Ricciardi S, Giovannoni D, Fulvi A, Migliorino MR, Marcassa C
OncoTargets and Therapy 2016, 9:4043-4052
Published Date: 4 July 2016
Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-Step I drugs in elderly patients with chronic pain at high risk of early opioid discontinuation
Lazzari M, Marcassa C, Natoli S, Carpenedo R, Caldarulo C, Silvi MB, Dauri M
Clinical Interventions in Aging 2016, 11:641-649
Published Date: 13 May 2016
Low-dose oral prolonged-release oxycodone/naloxone for chronic pain in elderly patients with cognitive impairment: an efficacy–tolerability pilot study
Petrò E, Ruffini E, Cappuccio M, Guerini V, Belotti G, Fascendini S, Licini C, Marcassa C
Neuropsychiatric Disease and Treatment 2016, 12:559-569
Published Date: 2 March 2016
Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis
Lazzari M, Greco MT, Marcassa C, Finocchi S, Caldarulo C, Corli O
Drug Design, Development and Therapy 2015, 9:5863-5872
Published Date: 2 November 2015